These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of rifampicin in the management of cutaneous leishmaniasis. Kochar DK; Aseri S; Sharma BV; Bumb RA; Mehta RD; Purohit SK QJM; 2000 Nov; 93(11):733-7. PubMed ID: 11077029 [TBL] [Abstract][Full Text] [Related]
6. Dermal leishmaniasis after kala-azar infection: successful treatment with rifampin. Saha SK Cutis; 1985 Jul; 36(1):81-2. PubMed ID: 4017660 [TBL] [Abstract][Full Text] [Related]
7. The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory mice. Weinrauch L; El-On J Trans R Soc Trop Med Hyg; 1984; 78(3):389-90. PubMed ID: 6087514 [No Abstract] [Full Text] [Related]
8. Rifampin therapy for brucellosis, flavobacterium meningitis, and cutaneous leishmaniasis. Conti R; Parenti F Rev Infect Dis; 1983; 5 Suppl 3():S600-5. PubMed ID: 6635449 [TBL] [Abstract][Full Text] [Related]
9. A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis. Kochar DK; Saini G; Kochar SK; Sirohi P; Bumb RA; Mehta RD; Purohit SK J Vector Borne Dis; 2006 Dec; 43(4):161-7. PubMed ID: 17175700 [TBL] [Abstract][Full Text] [Related]
10. Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis. Peters W; Lainson R; Shaw JJ; Robinson BL; Leão AF Lancet; 1981 May; 1(8230):1122-4. PubMed ID: 6112485 [TBL] [Abstract][Full Text] [Related]
11. [Cutaneous leishmaniasis: an autochtonous case in Switzerland?]. Mazzi R Dermatologica; 1976; 153(2):104-5. PubMed ID: 1001590 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of rifampicin and isoniazid against Leishmania tropica major. Livshin R; El-On J; Weinrauch L; Greenblatt CL; Even-Paz Z Int J Dermatol; 1983; 22(1):61. PubMed ID: 6832881 [No Abstract] [Full Text] [Related]
13. Failure of rifampin therapy to cure cutaneous leishmaniais. Bygbjerg IC; Knudsen L; Kieffer M Arch Dermatol; 1980 Sep; 116(9):988. PubMed ID: 7416770 [No Abstract] [Full Text] [Related]
14. Combination therapy of sodium stibogluconate and rifampin in cutaneous leishmaniasis. Pareek SS Int J Dermatol; 1984; 23(1):70-1. PubMed ID: 6327543 [TBL] [Abstract][Full Text] [Related]
15. Determination of healing response by immunostimulant therapy (levamisole) in cutaneous leishmaniasis. Makled M; Rifaat M; Azab M; Makhlouf S; El-Missery A; Khalil N Chemioterapia; 1987 Jun; 6(2 Suppl):214-6. PubMed ID: 3509936 [No Abstract] [Full Text] [Related]
17. [Pediatric clinical experimentation with rifampicin. Therapeutic effect and tolerance]. Valente G; Luvarà A Clin Pediatr (Bologna); 1969 Jan; 51(1):48-55. PubMed ID: 4933049 [No Abstract] [Full Text] [Related]
18. Leishmaniasis: a case history and treatment failure with rifampin. White SW; Hendricks LD; Chulay JD Arch Dermatol; 1980 Jun; 116(6):620-1. PubMed ID: 7377797 [No Abstract] [Full Text] [Related]
19. Visceral leishmaniasis treated with rifampicin and cotrimoxazole. Chatterjee S; Chatterjee R Indian Pediatr; 1993 May; 30(5):716-8. PubMed ID: 8282409 [No Abstract] [Full Text] [Related]
20. New World tegumentar leishmaniasis: chemotherapeutic activity of rifampicin in humans and experimental murine model. Do Valle TZ; Oliveira Neto MP; Schubach A; Lagrange PH; Da Costa SC Pathol Biol (Paris); 1995 Sep; 43(7):618-21. PubMed ID: 8570267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]